Home › Funds › BANQUE PICTET & CIE SA › MRNA
BANQUE PICTET & CIE SA position in MRNA
MODERNA INC · Health Care
BANQUE PICTET & CIE SA reported holding 2,151,259 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$414.3M, representing 6.11% of its reported portfolio and ranking #3 among its reported holdings. BANQUE PICTET & CIE SA has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR
How BANQUE PICTET & CIE SA's MRNA position evolved
BANQUE PICTET & CIE SA first disclosed a stake in MRNA in Q3 2023 at 3,143,427 shares (US$324.7M). The position peaked in Q3 2026 at 2,151,259 shares, worth US$414.3M. Across 13 filings, BANQUE PICTET & CIE SA increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 2,151,259 shares valued at US$414.3M — a reduction of -548,143 shares quarter over quarter.. Notable position changes include a 100% trim in Q2 2024 (shares fell 44% over the following quarter), a 30384% increase in Q3 2024 (shares fell 38% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.14M | $324.68M | New |
| Q4 2023 | 3.13M | $311.70M | Hold |
| Q1 2024 | 3.16M | $336.91M | Add |
| Q2 2024 | 10.35K | $1.23M | Reduce |
| Q3 2024 | 3.16M | $210.88M | Add |
| Q4 2024 | 3.13M | $130.27M | Reduce |
| Q1 2025 | 3.13M | $88.82M | Hold |
| Q2 2025 | 3.13M | $86.44M | Hold |
| Q3 2025 | 3.13M | $80.87M | Hold |
| Q4 2025 | 3.13M | $92.33M | Hold |
| Q1 2026 | 2.75M | $139.64M | Reduce |
| Q2 2026 | 2.70M | $189.04M | Reduce |
| Q3 2026 | 2.15M | $414.27M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRNA and 13F data
MRNA (MODERNA INC) is a Health Care company. 36 other funds we track also report a position in MRNA — the largest reported positions include Baillie Gifford & Co (US$1.28B), Theleme Partners LLP (US$564.3M), Flagship Pioneering, LLC (US$324.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRNA
- Baillie Gifford & Co 18.21M sh · $1.28B · Q2 2026
- Theleme Partners LLP 8.06M sh · $564.27M · Q2 2026
- Flagship Pioneering, LLC 4.63M sh · $324.39M · Q2 2026
- Douglas Lane & Associates, LLC 1.16M sh · $223.56M · Q3 2026
- Beau Ventures, LLc 1.00M sh · $192.58M · Q3 2026
- Merck & Co., Inc. 2.31M sh · $161.64M · Q2 2026
- Baron Funds 1.99M sh · $139.32M · Q2 2026
- BAMCO INC /NY/ 1.99M sh · $139.32M · Q2 2026
- IMC-Chicago, LLC 1.70M sh · $119.21M · Q2 2026
More on BANQUE PICTET & CIE SA
FAQ
How long has BANQUE PICTET & CIE SA held MRNA?
BANQUE PICTET & CIE SA has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is BANQUE PICTET & CIE SA's current position in MRNA?
As of Q3 2026, BANQUE PICTET & CIE SA holds 2.15M shares of MRNA (MODERNA INC), valued at $414.27M, representing 6.11% of its reported portfolio and ranking #3.
Has BANQUE PICTET & CIE SA been buying or selling MRNA?
In the latest 13F filing (Q3 2026), BANQUE PICTET & CIE SA reduced its position in MRNA. The position peaked in Q3 2026 at 2.15M shares.
Which other funds hold MRNA?
Other major institutional holders of MRNA include Baillie Gifford & Co, Theleme Partners LLP, Flagship Pioneering, LLC, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.